The adaptor ASC contributes to innate immunity through the assembly of inflammasome complexes that activate the cysteine protease caspase-1. Here we demonstrate that ASC has an inflammasome-independent, cell-intrinsic role in cells of the adaptive immune response. ASC-deficient mice showed defective antigen presentation by dendritic cells (DCs) and lymphocyte migration due to impaired actin polymerization mediated by the small GTPase Rac. Genome-wide analysis showed that ASC, but not the cytoplasmic receptor NLRP3 or caspase-1, controlled the mRNA stability and expression of Dock2, a guanine nucleotideexchange factor that mediates Rac-dependent signaling in cells of the immune response. Dock2-deficient DCs showed defective antigen uptake similar to that of ASC-deficient cells. Ectopic expression of Dock2 in ASC-deficient cells restored Rac-mediated actin polymerization, antigen uptake and chemotaxis. Thus, ASC shapes adaptive immunity independently of inflammasomes by modulating Dock2-dependent Rac activation and actin polymerization in DCs and lymphocytes. nature immunology A r t i c l e s cells independently of inflammasomes. Instead, ASC controlled the stability of Dock2 transcripts and expression of Dock2. Our observations identify a previously unknown role for ASC in regulating adaptive immune responses that is intrinsic to lymphocytes and DCs. The vital role of ASC in regulating both adaptive and innate immune responses suggests that modulating ASC expression and function may represent a powerful therapeutic strategy for the treatment of inflammatory and autoimmune disorders.
Inflammasomes are intracellular multiprotein complexes that are emerging as key regulators of the innate immune response. Deregulated inflammasome activity has been linked to autoimmune diseases, including inflammatory bowel diseases [1] [2] [3] [4] [5] , vitiligo 6 , gouty arthritis 7 and type I and type II diabetes 8, 9 and less common autoinflammatory disorders collectively referred to as 'cryopyrinopathies' 10, 11 . Distinct inflammasome complexes are assembled around members of the Nod-like receptor (NLR) family or DNA-binding HIN-200 family in a pathogen-specific manner [12] [13] [14] . NLRC4 assembles an inflammasome in macrophages infected with intracellular pathogens such as Salmonella typhimurium, Legionella pneumophila, Pseudomonas aeruginosa and Shigella flexneri [15] [16] [17] [18] [19] [20] [21] [22] . In contrast, lethal toxin from Bacillus anthracis triggers activation of the NLRP1B inflammasome in mouse macrophages, and Nlrp1b has been identified as the key susceptibility locus for anthrax lethal toxin-induced macrophage death 23 . NLRP3 mediates activation of the cysteine protease caspase-1 in lipopolysaccharide (LPS)-primed macrophages that are exposed to microbial components with diverse molecular structures such as viral RNA and DNA or microbial toxins such as the ionophore nigericin 17, [24] [25] [26] [27] . In addition, the endogenous danger-associated molecules monosodium urate and calcium pyrophosphate dehydrate crystals also activate the NLRP3 inflammasome, which suggests a role for this inflammasome in the etiology of gouty arthritis and pseudogout 7 . The NLRP3 inflammasome contributes to host defense against Salmonella infection in vivo 28 . Moreover, published reports have characterized the critical role of the NLRP3 inflammasome in protection against colitis and colitis-associated tumorigenesis 2, 3, 5 . Finally, DNA viruses such as vaccinia virus and cytomegalovirus and the bacterial pathogens Francisella tularensis and Listeria monocytogenes induce activation of caspase-1 through the HIN-200 family member AIM2 (refs. [29] [30] [31] [32] [33] [34] . Once activated, caspase-1 cleaves and allows secretion of bioactive interleukin 1β (IL-1β) and IL-18. In addition, caspase-1 mediates a specialized form of cell death in infected macrophages and dendritic cells (DCs), a process that contributes substantially to the pathophysiology of several infectious diseases 12, 35 .
The adaptor ASC (Pycard) was initially believed to exert its effects on immune signaling mainly by bridging the interaction between NLRs or HIN-200 proteins and caspase-1 in inflammasome complexes 36, 37 . However, emerging evidence has indicated important inflammasomeindependent roles for ASC in controlling immune responses. For instance, the adjuvant quality of the oil-in-water emulsion MF59 has been shown to require ASC, whereas the inflammasome components NLRP3 and caspase-1 are dispensable 38 . Consequently, the induction of antigen-specific γ-immunoglobulin (IgG) antibodies to influenza vaccines in MF59 is impaired in mice that lack ASC (Pycard −/− ; called 'Asc −/− ' here) but not in NLRP3-deficient (Nlrp3 −/− ) mice or caspase-1-deficient (Casp1 −/− ) mice 38 . Moreover, granuloma formation and host defense in chronic Mycobacterium tuberculosis infection depends A r t i c l e s on ASC but not on NLRP3 or caspase-1 (ref. 39 ). Finally, Asc −/− mice, but not Nlrp3 −/− mice or Casp1 −/− mice, are substantially protected against disease progression in experimental models of rheumatoid arthritis and experimental autoimmune encephalomyelitis (EAE), respectively [40] [41] [42] . Those last studies have indicated the existence of cell-intrinsic roles for ASC in DC and lymphocyte populations. However, the molecular effector mechanism by which ASC regulates adaptive immune responses independently of inflammasomes has remained unclear.
Here we show that ASC has a critical cell-intrinsic role in regulating immune-cell functions in lymphocytes and DCs in an inflammasomeindependent manner. The chemotaxis of Asc −/− lymphocytes, but not of Nlrp3 −/− or Casp1 −/− lymphocytes, was considerably impaired despite normal expression of chemokine receptors and downstream mitogen-activated protein kinase (MAPK) signaling. Instead, Asc −/− lymphocytes failed to migrate because of defective actin polymerization induced by the small GTPase Rac at the leading edge of leukocytes. Consequently, total lymphocyte and DC populations in secondary lymphoid organs were much smaller in Asc −/− mice but not in Nlrp3 −/− or Casp1 −/− mice. Rac activation and actin polymerization have a critical role in other cell type functions as well, including the uptake of antigens by DCs 43 . Accordingly, ASC-deficient DCs were impaired in their ability to take up antigens and to drive T cell proliferation. Again, inflammasome signaling was dispensable for ASC-mediated antigen presentation and T cell activation. Instead, transcriptome analysis showed that ASC specifically regulated the transcript abundance of Dock2, a guanine nucleotide-exchange factor specific for cells of the immune response that mediates Rac-dependent actin polymerization and migration of T cells and B cells 44 . As in Asc −/− cells, we identified a critical role for Dock2 in antigen uptake by DCs. Moreover, ectopic expression of Dock2 in Asc −/− lymphocytes and DCs restored ASC-dependent immune functions, which confirmed that Dock2 is the main effector that drives the inflammasome-independent functions of ASC in cells of the immune response. Thus, ASC regulates adaptive immune responses by controlling Dock2 expression in DCs and lymphocytes. Our results identify a previously unknown mechanism that regulates the function of cells of the adaptive immune response and provide a mechanistic explanation for the critical inflammasome-independent role of ASC in driving T cell and humoral responses after vaccination and in autoimmune disease.
RESULTS

Antigen uptake and presentation require ASC
The presentation of antigenic peptides on receptors for major histocompatibility complex class II of 'professional' phagocytes represents a critical step in the activation of adaptive immune responses that is dependent on actin polymerization 43 . We confirmed the critical role of ASC in antigen presentation by receptors for major histocompatibility complex class II with the observation that Asc −/− DCs were severely impaired in inducing the proliferation of bovine serum albumin (BSA)-specific T cells ( Fig. 1a) . Moreover, wild-type T cells incubated with Asc −/− DCs in the presence of BSA produced significantly lower amounts cytokines of the T helper type 1 (T H 1) subset (interferon-γ; Fig. 1b) , the T H 2 subset (IL-6 and IL-10; Fig. 1c and Supplementary Fig. 1 ) and the T H 17 subset of helper T cells (IL-17; Fig. 1d ), which further established the critical role for ASC in priming T cells. Unlike Asc −/− DCs, Nlrp3 −/− DCs and Casp1 −/− DCs elicited a T cell-proliferative response similar to that induced by wild-type DCs (data not shown), which emphasizes the role of ASC in antigen presentation by DCs that is independent of its role in inflammasome activation.
The recognition and uptake of antigen by professional antigenpresenting cells represents one of the first steps in presenting peptides to receptors for major histocompatibility class II (ref. 43) . To explore the possibility that ASC is required for antigen uptake by professional phagocytes, we incubated wild-type, Nlrp3 −/− , Asc −/− and Casp1 −/− bone marrow-derived DCs (BMDCs) for 3 h with fluorescein isothiocyanate (FITC)-labeled zymosan A or polystyrene beads and measured phagocytosis by flow cytometry. Internalization of zymosan A or polystyrene beads by Asc −/− BMDCs was impaired, whereas phagocytosis by Nlrp3 −/− and Casp1 −/− BMDCs was similar to that of wild-type cells (Fig. 1e) . This result confirmed that Asc −/− BMDCs were defective in the phagocytosis of particulate antigens. To determine whether the uptake of small soluble antigens, which proceeds via fluid endocytosis (macropinosis), was also affected by ASC deficiency, we incubated wild-type, Nlrp3 −/− , Asc −/− and Casp1 −/− BMDCs for 3 h with FITC-labeled dextran, FITC-labeled ovalbumin (OVA) or lucifer yellow, then washed the cells and assessed macropinosis of these substances by flow cytometry. Asc −/− DCs were defective in internalizing all three; in contrast, macropinosis of these by Nlrp3 −/− and Casp1 −/− BMDCs was not affected (Fig. 1f ). Together these results indicate that ASC controls the uptake and presentation of antigens in professional antigen-presenting cells independently of inflammasomes. 1 0 1 2 VOLUME 12 NUMBER 10 OCTOBER 2011 nature immunology A r t i c l e s ASC is critical for lymphocyte chemotaxis and migration In addition to its role in regulating antigen uptake by professional phagocytes, ASC has been proposed to exert cell-intrinsic functions in lymphocytes 41, 42 . In agreement with that, the total number of spleen and lymph node cells in Asc −/− mice was about half of that in wild-type mice, with counts of CD4 + T cells, CD8 + T cells, B cells and CD11c + cells all much lower in Asc −/− spleens and lymph nodes ( Fig. 2a ). Nlrp3 −/− and Casp1 −/− mice had numbers similar to those of wild-type mice in both the spleen and lymph nodes for each cell population ( Supplementary Fig. 2 ). To determine whether ASC has an important role during lymphocyte migration and T cell development, we analyzed the migration of congenically marked wild-type and Asc −/− lymphocytes to peripheral lymph nodes and spleens of wildtype mice. The intrinsic migratory ability of Asc −/− T cells and B cells was impaired, as indicated by the significantly lower number of both cell types retrieved from the spleen and lymph nodes of wild-type hosts ( Fig. 2b) . To confirm the intrinsic migratory defect of Asc −/− lymphocytes, we created mixed chimeras by injecting an equal ratio of wild-type and Asc −/− bone marrow into lethally irradiated wildtype mice. At 6 weeks after reconstitution, ~98% of the CD4 + T cells found in blood and secondary lymphoid organs were derived from wild-type bone marrow ( Fig. 2c) . Similarly, most circulating B cells were wild-type cells (Fig. 2c) . In addition to being the result of intrinsic defects in migration, the very high ratio of wild-type lymphocytes to Asc −/− lymphocytes in mixed chimeras could also have been due to differences in lymphocyte development and cell survival. Although leukocyte populations in Asc −/− mice (Supplementary Fig. 3 ) and chimera mice with Asc −/− bone marrow ( Supplementary Fig. 4 ) indeed contained slightly fewer single-positive (CD4 + or CD8 + ) thymocytes and modestly more double-negative (CD4 − CD8 − ) T cells, these differences in thymocyte development were only minor. Nevertheless, to further confirm the migratory phenotype of Asc −/− T cells and B cells, we studied the in vitro migration of these cells toward chemokines. In agreement with a critical role for ASC in lymphocyte chemotaxis, splenic CD4 + T cells from Asc −/− mice were nearly completely unable to migrate toward the chemokines SDF-1 and SLC ( Fig. 2d) .
Similarly, B cells from Asc −/− mice were defective in their migration toward both SDF-1 and the lymphocyte chemokine BLC ( Fig. 2e) .
In contrast, splenic T lymphocytes and B lymphocytes of Nlrp3 −/− and Casp1 −/− mice migrated toward these chemokines to a degree similar to that of wild-type lymphocytes (Supplementary Fig. 5 ). Thus, ASC is required for lymphocyte migration in vitro and in vivo.
ASC controls Rac activation and actin polymerization
Both efficient endocytosis of antigens and the migration of lymphocytes toward a chemokine gradient require the activation of small GTPases such as Cdc42 and Rac to induce F-actin polymerization and cytoskeletal reorganization 43 . However, the expression and activation of Cdc42 were not altered in Asc −/− BMDCs and lymphocytes, respectively ( Supplementary Fig. 6 ). In contrast, Asc −/− BMDCs were impaired in Rac activation ( Fig. 3a) and F-actin polymerization ( Fig. 3b ) when incubated with OVA. Because lymphocyte migration relies on Rac activation and actin polymerization induced by chemokine receptors, we assessed the extent of Rac activation after chemokine stimulation. Although wildtype CD4 + T cells and B cells activated Rac ( Fig. 3c ) and induced F-actin polymerization ( Fig. 3d ) after incubation with SDF-1 (500 ng/ml), these responses were much lower in Asc −/− T cells and B cells ( Fig. 3c,d) . The role of ASC in Rac activation and F-actin polymerization induced by chemokines in lymphocytes was specific, because SDF-1-induced activation of the MAPK Erk was not affected in Asc −/− T lymphocytes and B lymphocytes ( Supplementary Fig. 7) . Thus, defective antigen uptake by Asc −/− DCs and chemotaxis of Asc −/− lymphocytes is linked to impaired Rac activation and F-actin polymerization in these cells.
ASC regulates Dock2 expression independently of inflammasomes
Our results showed that ASC regulates antigen uptake in DCs and the migration of lymphocytes independently of inflammasomes through the modulation of Rac activation and F-actin polymerization. To characterize the molecular mechanism involved, we did microarray experiments to identify genes dysregulated in Asc −/− BMDCs despite their normal expression in Nlrp3 −/− or Casp1 −/− cells. Notably, among the more than 39,000 transcripts present on the microarray, the transcripts of only 5 genes were downregulated at least 66% in Asc −/− BMDCs relative to their expression in wild-type BMDCs (Fig. 4a) . In addition to Asc, these included Dock2 (80%) and the genes encoding follistatin-like 1 protein (Fstl1; 80%), galanin (Gal; 73%) and fatty acid-binding protein 4 (Fabp4; 70%). Quantitative PCR analysis confirmed the lower expression of Dock2 mRNA in Asc −/− BMDCs (Fig. 4b) , but the expression of Fstl1, Gal and Fabp4 was unaltered in Asc −/− BMDCs (data not shown).
Unlike Asc −/− BMDCs, Nlrp3 −/− and Casp1 −/− BMDCs had normal abundance of Dock2 mRNA (Fig. 4b) , which confirmed that Dock2 transcript abundance is regulated by ASC in an inflammasome-independent manner. We observed similarly lower Dock2 transcript abundance in the absence of ASC in CD4 + T cells and isolated B cells ( Fig. 4c) . In contrast, Dock2 mRNA expression in Nlrp3 −/− and Casp1 −/− CD4 + T cells and B cells was similar to that of wild-type cells (data not shown). We next prepared lysates of wild-type, Nlrp3 −/− , Asc −/− and Casp1 −/− BMDCs to assess the expression of Dock2, FSTL1, FABP4 and galanin by immunoblot analysis. Notably, Dock2 expression was nearly abolished in Asc −/− BMDCs but was not altered in Nlrp3 −/− and Casp1 −/− BMDCs (Fig. 4d) . The expression of FSTL1, galanin and FABP4 was not altered in Asc −/− BMDCs (Fig. 4d) , which confirmed the results of quantitative PCR. Additionally, activation of the NLRP3 inflammasome by stimulation with LPS and ATP did not upregulate Dock2 expression in Asc −/− BMDCs or macrophages ( Supplementary Fig. 8 ). Moreover, Dock2 expression remained stable in Nlrp3 −/− and Casp1 −/− BMDCs treated with those stimuli (Supplementary Fig 8) . We confirmed ASC-dependent Dock2 expression in the BMDMs used above and BMDCs from an independently generated line of ASC-deficient mice 45 (Supplementary Fig. 9 ). We also observed the nearly complete absence of Dock2 protein in Asc −/− T cells and B cells ( Fig. 4e) . These results indicate that ASC specifically regulates Dock2 expression in an inflammasome-independent manner in myeloid cells and lymphocytes. We also explored whether ASC regulates Dock2 expression in a Tolllike receptor (TLR)-dependent way, but Dock2 expression was normal in BMDCs isolated from mice deficient in TLR2 or TLR4, as well as in cells lacking the common TLR adaptors MyD88 or TRIF (Fig. 4f) . Thus, ASC specifically regulates Dock2 expression in myeloid cells and lymphocytes in a TLR-and inflammasome-independent way.
ASC regulates Dock2 mRNA stability To characterize the mechanism by which ASC regulates Dock2 mRNA abundance, we first analyzed the subcellular localization of ASC in BMDCs by subcellular fractionation. Notably, we detected ASC in both the cytosolic and nuclear fractions of naive BMDCs (Fig. 5a) . The subcellular localization of ASC to these compartments remained largely stable after stimulation with LPS and ATP ( Fig. 5a) . As expected, the antibody to ASC did not detect immunoreactive bands in lysates of Asc −/− BMDCs, which confirmed its specificity. Unlike ASC, caspase-1 was located exclusively in the cytosol of naive and BMDCs stimulated with LPS and ATP ( Fig. 5a) , which suggested that the nuclear pool of ASC is not recruited to inflammasome complexes. In agreement with that, analysis of confocal micrographs indicated that ASC and caspase-1 localized together in the 1 0 1 4 VOLUME 12 NUMBER 10 OCTOBER 2011 nature immunology A r t i c l e s cytosol of BMDCs stimulated with LPS and ATP but not in untreated BMDCs (Fig. 5b) . In contrast, ASC located in the nuclear compartment failed to localize together with caspase-1 under these conditions (Fig. 5b) , which suggested that nuclear ASC may be responsible for regulating Dock2 mRNA abundance in an inflammasome-independent manner. We next assessed whether nuclear ASC regulated the transcriptional activity of the Dock2 promoter. For this, we cloned the Dock2 promoter into a luciferase reporter vector and used this to analyze Dock2 promoter-driven luciferase production in wild-type and Asc −/− BMDCs. Luciferase expression was induced similarly in wild-type and Asc −/− BMDCs (Fig. 5c) , which suggested that ASC may regulate Dock2 mRNA abundance via mRNA stability instead. To investigate this possibility, we assessed Dock2 mRNA stability in wild-type and Asc −/− BMDCs after treatment with the reversible transcription inhibitor DRB or actinomycin D to block new transcription. The half-life of Dock2 transcripts was much lower in Asc −/− BMDCs (30 min) than in wild-type cells (~4 h; Fig. 5d ). Unlike the half-life of Dock2 mRNA, the half-life of Actb mRNA (encoding β-actin) was almost completely unaffected in Asc −/− BMDCs (Fig. 5d) , which confirmed the specificity of these results. Thus, regulation of Dock2 mRNA stability represents a major mechanism by which ASC controls Dock2 expression. To examine the potential contribution of post-translational events to the regulation of Dock2 expression, we pretreated wild-type and Asc −/− cells for 1, 4 or 6 h with the proteasome inhibitor MG132 before probing lysates for Dock2 expression. Proteasome inhibition resulted in slightly higher Dock2 expression in wild-type cells, but this was not sufficient to restore expression in Asc −/− cells (Supplementary Fig. 10 ).
Dock2 is critical for antigen uptake by DCs
Dock2 is member of a conserved family of guanine nucleotideexchange factors that is specific to cells of the immune response and has been identified as a central regulator of the migration of lymphocytes and plasmacytoid DCs that controls Rac-dependent actin polymerization and cytoskeletal reorganization in these cells 44, 46, 47 . However, its role in DC function has not been characterized. We hypothesized that similar to Asc −/− BMDCs (Fig. 1) , professional phagocytes lacking Dock2 might be impaired in antigen uptake and endocytosis. We first examined the macropinosis of FITC-labeled dextran, FITC-OVA and lucifer yellow by wild-type and Dock2 −/− BMDCs. The uptake of dextran ( Fig. 6a) , OVA ( Fig. 6b) and lucifer yellow (Fig. 6c) by Dock2 −/− BMDCs was significantly impaired relative to their uptake by wild-type BMDCs, which indicated the importance of Dock2 in the endocytosis of soluble antigens by professional phagocytes. The uptake of larger particles and insoluble antigens proceeds through phagocytosis rather than macropinosis 48 . To determine the role of Dock2 in phagocytosis, we compared the uptake of FITC-labeled zymosan A and FITC-labeled polystyrene beads by wild-type and Dock2 −/− BMDCs. In agreement with an important role for Dock2 in phagocytosis, Dock2 −/− DCs were impaired in the internalization of zymosan A (Fig. 6d ) and polystyrene beads ( Fig. 6e) relative to the internalization of these by wild-type control cells. Notably, ASC expression and inflammasome activation were normal in Dock2 −/− BMDCs (Supplementary Fig. 11) , which further confirmed that ASC-and Dock2-mediated endocytosis is uncoupled from inflammasome signaling.
Ectopic expression of Dock2 restores ASC-mediated functions
The observation that Dock2 was critical for the internalization of soluble and insoluble antigens via both macropinosis and phagocytosis by professional antigen-presenting cells, together with our results showing that ASC controlled Dock2 expression in BMDCs and lymphocytes ( Figs. 4 and 5) , suggested that ASC may act upstream of Dock2 in controlling Dock2-dependent immune functions. Therefore, we assessed whether the defective Rac activation, actin polymerization and antigen uptake by Asc −/− BMDCs and impaired migration of Asc −/− lymphocytes was due to the specific downregulation of Dock2 in these cells. For this, we transfected Asc −/− BMDCs by nucleofection with plasmid encoding green fluorescent protein (GFP) alone or a GFP-Dock2 fusion protein. Endocytosis of OVA by Asc −/− BMDCs expressing GFP-Dock2 was significantly higher than its uptake by Asc −/− BMDCs expressing GFP alone (Fig. 6f) , which confirmed the requirement for Dock2 downstream of ASC for antigen uptake by professional phagocytes. Similarly, ectopic expression of Dock2 in Asc −/− T cells restored their migration toward the chemokine SLC (Fig. 6g) . Collectively, these data show that the functional defects of Asc −/− BMDCs and lymphocytes were due to a specific decrease in Dock2 mRNA stability that led to impaired Dock2 expression in the absence of ASC and that ectopic expression of Dock2 in the cells was sufficient to restore ASC-dependent immune-cell functions.
DISCUSSION
The adaptor ASC is well known to contribute to innate immune responses by enabling activation of the cysteine protease caspase-1 in inflammasomes 45, 49 . Studies have provided evidence indicating that Asc −/− mice are protected from disease progression in animal models of arthritis and multiple sclerosis, whereas mice lacking the inflammasome components NLRP3 or caspase-1 are not [40] [41] [42] . ASC has been suggested to affect the immune-cell functions of lymphocytes 41, 42 and DCs 40 . Although such observations suggest that ASC controls immunecell functions through inflammasome-independent mechanisms, the molecular pathways involved have remained unclear. ASC has been reported to regulate the activation of MAPKs in macrophages by interacting with the phosphatase DUSP10 in response to TLR ligands and infection with bacterial pathogens 50 . However, this function may be stimulus dependent, as earlier reports did not observe differences in MAPK signaling in activated and infected Asc −/− macrophages 45 . Furthermore, we failed to detect changes in chemokine-induced phosphorylation of Erk in Asc −/− cells of the immune response.
Instead, we found that antigen presentation by DCs and the migration of T lymphocytes and B lymphocytes were considerably diminished in Asc −/− mice as a result of impaired Rac-mediated actin polymerization. Microarray and immunoblot analysis of naive and stimulated Asc −/− DCs and lymphocytes showed that ASC specifically regulated Dock2 expression. The role of ASC in regulating the abundance of Dock2 mRNA was highly specific, as only 5 transcripts of the 39,000 transcripts analyzed were up-or downregulated by at least 66% in Asc −/− BMDCs relative to their expression in wild-type BMDCs. Moreover, Dock2 was the only ASC-regulated gene whose expression was altered at the protein level as well. Instead of directly affecting Dock2 promoter activity, ASC had a critical role in stabilizing Dock2 mRNA, as the half-life of Dock2 transcripts was much lower (87.5%) in Asc −/− DCs. Further analysis is needed to determine the specific contribution of the nuclear and cytosolic pools of ASC to this process. Given that ASC lacks intrinsic enzymatic activity, ASC most probably affects Dock2 abundance by assembling one or more protein complex(es) in the cytosol and/or nucleus, distinct from the inflammasomes. Moreover, in addition to regulating the decay rate of Dock2 transcripts, ASC may contribute to as-yet-unknown processes that regulate Dock2 mRNA and Dock2 protein at the post-transcriptional and/or post-translational level. These may include microRNAs that target Dock2, splicing of Dock2 mRNA linked to nonsense-mediated mRNA decay, trafficking of Dock2 mRNA, the rate of Dock2 translation and the degree of post-translational modification that may influence the trafficking and degradation of Dock2 in lysosomes. However, the notable effect of ASC deficiency on the decay rate of Dock2 mRNA may hamper detailed analysis of the potential role of ASC in regulating Dock2 expression through these additional mechanisms. Regardless of what proves to be true, we confirmed downregulated Dock2 expression as the mechanism that drove the defective phagocytosis and antigen presentation by DCs and dysfunctional chemotaxis of lymphocytes in the absence of ASC. For example, ectopic expression of Dock2 in ASC-deficient cells restored lymphocyte migration and antigen uptake by DCs. Thus, the observation that ASC controlled Dock2 expression and Dock2-mediated regulation of Rac activation and actin polymerization provides a molecular basis for the defective antigen presentation by DCs and the lymphocyte-intrinsic defects in cell migration observed in the studies cited above.
In conclusion, we have provided genetic evidence of a critical and unexpected role for ASC in regulating the motility of T lymphocytes and B lymphocytes and antigen uptake by professional antigen-presenting 
ONLINE METHODS
Mice. Both independent Asc −/− mouse lines used in this study have been characterized 45, 51 . Nlrp3 −/− , Casp1 −/− , Tlr2 −/− , Tlr4 −/− , MyD88 −/− , Trif −/− and Dock2 −/− mice have been described 2, 44 . All mice were backcrossed at least ten generations to the C57BL/6J genetic background. Mice were housed in a pathogen-free facility and animal studies were conducted under protocols approved by St. Jude Children's Research Hospital Committee on Use and Care of Animals or by the Ghent University Hospital ethical committee.
Microarray analysis and quantitative PCR. The quality of isolated RNA was confirmed with an Agilent 2100 Bioanalyzer before microarray analysis. RNA samples were processed on an HT MG-430 PM array plate with the Affymetrix GeneTitan system. Three biological replicates of naive wild-type and Asc −/− BMDCs were analyzed by microarray, and transcript expression values were summarized by the robust multi-array average method 52 .
Differences between wild-type and Asc −/− BMDCs in gene expression were analyzed by an empirical Bayesian method (Cyber-T statistics program) 53 , and the false-discovery rate was estimated as described 54 . For quantitative PCR analysis of Dock2, samples were amplified with specific primers (forward, 5′-TTGCTCAGCCAGCTACTGTATG-3′; reverse, 5′-TTGG TGATGACAGGAAGCAGAAT-3′). Quantification was normalized relative to expression of the reference gene Gapdh.
Subcellular fractionation. Cytoplasmic and nuclear fraction extractions were prepared with NE-PER Nuclear and Cytoplasmic Extraction Reagents according to the manufacturer's instructions (Pierce).
Immunoblot analysis.
Standardized protein concentrations of cellular lysates were separated by SDS-PAGE. Antibody to Dock2 (anti-Dock2; 09-454), anti-ASC (AL177; Enzo Life Sciences), anti-caspase-1 (a gift from P. Vandenabeele), anti-FSTL1 (AF1738; R&D Systems), anti-FABP4 (2120; Cell Signaling Technology), anti-galanin (ab99452; Abcam) and anti-β-actin (4970; Cell Signaling Technology) were used at a final dilution of 1:1,000. Proteins were detected by horseradish peroxidase-based enhanced chemiluminescence (34095; Thermo Scientific).
Transfection. Immature BMDCs were transfected with a Nucleofector kit (VPA-1009; Lonza) and were incubated at 37 °C for 24 h before antigen-uptake assays.
Retroviral transduction. GFP-Dock2 and GFP were cloned into a mouse stem cell virus retroviral vector. Phoenix-Eco packaging cells were transfected with Lipofectamine 2000 (11668-027; Invitrogen), and recombinant viruses were collected 48 h and 72 h after transfection. Total spleen cells were isolated and cultured for 24 h with anti-CD3 (2.5 µg/ml; 145-2C11; eBioscience), anti-CD28 (5 µg/ml; 37.51; eBioscience) and IL-2 (100 U/ml) and then transduced with retrovirus by 'spin inoculation' . GFP + cells were sorted by flow cytometry and then used for chemotaxis assays. Cultures were maintained for 72 h at 37 °C and 5% CO2 in U-bottomed plates in 300 µl HL-1 medium (7720; Lonza) supplemented with penicillin G (50 U/ml) and streptomycin (50 µg/ml), 2-mercaptoethanol (50 µM), l-glutamine (292 µg/ml) and 0.1% (wt/vol) BSA. Supernatants were collected for evaluation of cytokine production and cultures were pulsed with [ 3 H]thymidine (1 µCi/well in 10 µl), then were incubated for an additional 18 h and collected onto UniFilter GF/C plates, then radioactivity was measured as counts per minute on a TopCount NXT microplate scintillation counter (PerkinElmer).
Cytokine measurement. Cytokines were measured with a Milliplex ELISA kit (Millipore).
Flow cytometry. For flow cytometry, cells were stained with anti-CD4 (L3T4), anti-CD8 (53-6.7), anti-CD11b (M1/70) or anti-B220 (RA3-6B2; all from eBioscience); or anti-CD8α (53-6.7), anti-TCRβ (H57-597), anti-CD44 (IM7), anti-CD69 (H1.2F3), anti-CD11c (N418), anti-CD45.1 (A20) or anti-CD45.2 (104; all from Biolegend); after staining, cells were analyzed on an LSR II (Becton-Dickinson). For analysis of antigen uptake and phagocytosis, DCs were incubated for 3 h with fluorochrome-conjugated OVA, dextran, luciferase yellow, zymosan A or beads. Cells were washed several times and analyzed by flow cytometry. For analysis of actin polymerization, isolated T cells and B cells were fixed in 4% (vol/vol) paraformaldehyde, made permeable with Permeabilization Wash Buffer (421002; Biolegend) and stained with Alexa Fluor 488-labeled phalloidin (BD Biosciences) for flow cytometry. Chemotaxis assay. Splenocytes (1.5 × 10 6 ) in 100 µl RPMI medium were placed in Transwell permeable supports (pore size, 5 µm), which were placed onto 24-well plates containing 500 µl RPMI medium supplemented with chemokines (R&D Systems) at various concentrations. Cells were incubated for 3 h at 37 °C. Cells placed in the Transwell supports and those that migrated to the lower chamber were collected and stained with anti-TCRβ (H57-597; eBioscience) and anti-B220 (RA3-6B2; eBioscience).
GTPase activity assay. The GTPase activity of Cdc42 and Rac1 in cell extracts was measured by G-LISA activation assay (BK127 (for Cdc42) and BK127 (for Rac1); Cytoskeleton).
Assay of mRNA stability. New transcription was inhibited by culture of BMDCs in the presence of DRB (5,6-dichloro-1-β-ribofuranosyl
Published reports suggest that the inflammasome adaptor ASC regulates immune responses independently of its well-known role in inflammasomes. In this context, ASC-deficient mice (Pycard -/mice; called 'Asc -/mice' here) have been found to be resistant to antigen-and collagen-induced arthritis and experimental autoimmune encephalomyelitis, but mice deficient in the cytoplasmic receptor NLRP3 (Nlrp3 -/mice) or caspase-1 (Casp1 -/-; as noted below, these mice are actually doubly deficient in caspase-1 and caspase-11) 1 are not [2] [3] [4] . In addition, granuloma formation and host defense during chronic infection with Mycobacterium tuberculosis has been suggested to require ASC but not NLRP3 or caspase-1 (ref. 1). In our article, we reported defective expression of the guanine nucleotide-exchange factor Dock2 in the bone marrow-derived macrophages (BMDMs), bone marrow-derived dendritic cells (BMDCs), T cells and B cells of mice with targeted deletion of Asc 5 , thereby providing a possible explanation for the previously reported defects in antigen presentation and lymphocyte migration in these mice 4- . In this context, Dock2 has already been established as a central regulator of the migration of lymphocytes and plasmacytoid dendritic cells [6] [7] [8] . In addition, we demonstrated defective antigen uptake in Dock2-deficient BMDCs similar to that of ASC-deficient cells and that ectopic expression of Dock2 in ASC-deficient BMDCs and lymphocytes restored antigen uptake and lymphocyte migration, respectively 5 .
In our facility, we have specifically observed defective Dock2 expression in Asc -/mice, but not in mice deficient in the kinase RICK (Ripk2 -/mice), the cytosolic pattern-recognition receptor Nod2 (Nod2 -/mice), the adaptors CARD9 (Card9 -/mice), TRIF (Ticam1 -/mice; called 'Trif -/mice' here) or MyD88 (Myd88 -/mice), the cytosolic pattern-recognition receptors Nod1 and Nod2 (Nod1 -/-Nod2 -/mice), the signaling adaptor MAVS (Mavs -/mice), or the pattern-recognition receptor NLRC4 (Nlrc4 -/mice) or in Nlrp3 -/mice (Fig. 1a) . Moreover, defective Dock2 expression has been verified in BMDMs and BMDCs from two independently generated lines of ASC-deficient mice housed in two separate facilities (St Jude Children's Research Hospital, Memphis, Tennessee, USA, and Ghent University, Ghent, Belgium) 5 , which makes it unlikely that this is a strain-specific anomaly. The two lines of ASC-deficient mice available to us were generated through the use of embryonic stem cells from mice of the 129 strain 9, 10 . Notably, a published study has shown that Casp1 -/mice also lack caspase-11 expression because of a mutation in the locus encoding caspase-11 (Casp4; called 'Casp11' here) in the 129 embryonic stem cells used to generate these mice 11 . However, unlike the Casp1 and Casp11 loci, the Asc and Dock2 loci reside on separate chromosomes. Moreover, genome-wide single-nucleotide polymorphism (SNP) analysis has confirmed that both of our ASC-deficient mouse lines are approximately 98% identical to C57BL/6 mice (Fig. 1b) . In addition, we have found normal expression of Dock2 in BMDCs of C57BL/6, 129S1/SvImJ and BALB/c mice (Fig.  1c) , which suggests that the defective Dock2 expression in these ASC-deficient mice cannot be attributed to their overall genetic background. However, when we examined Dock2 expression in Asc -/mice from other investigators' facilities, we unexpectedly observed defective Dock2 expression in BMDCs and BMDMs of some, but not all, ASC-deficient mouse lines ( Fig. 1d,e) .
As our results were highly reproducible, we believe the most probable explanation for the differences in Dock2 expression in different ASCdeficient lines may be subtle differences in genetic background and/or environmental factors. In this context, Asc -/mice have been shown to harbor an altered microflora composition, which leads to the development of a severe dextran sodium sulfate-induced colitis that is transferable to wild-type mice housed together with newborn Asc -/mice that were cross-fostered at birth with wild-type mothers 12 . Alternatively, ASC-deficient mouse lines that fail to express Dock2 may be hemi-or homozygous for an inactivating 'passenger' mutation of Dock2. In this context, a spontaneous genomic duplication and frameshift mutation in Dock2 that reaches homozygosity has been reported to complicate the interpretation of interferon and antibody responses in at least a subset of available mice deficient in the transcription factor IRF5 (ref. 13 ). Further analysis is warranted, although sequencing of PCR-amplified Dock2 cDNA isolated from ASC-deficient macrophages with lower Dock2 expression (lines 1 and 2) has failed to identify any missense mutations in Dock2 (Fig. 1f) .
In conclusion, the precise reasons for the differences in Dock2 expression in some, but not all, ASC-deficient mouse lines remain unclear and should be explored further in future experiments. Nevertheless, our new experimental data emphasize the proposal that verifying the Dock2-expression status of the various ASC-deficient mouse lines now available is imperative for proper determination and interpretation of the inflammasome-dependent and inflammasome-independent phenotypes of these mice. chr01  chr01  chr02  chr02  chr03  chr03  chr04  chr04   chr06   chr05   chr06  chr07  chr08  chr08  chr09  chr10  chr10  chr11  chr12  chr12  chr13  chr13  chr14  chr15  chr15  chr16  chr17  chr17  chr18 chr19 chrX 
